Table 2 Content of Se, GSH-Px activity and TAS in the serum of patients with multiple sclerosis (MS) and in the control group
Selenium (μg/L) | GSH – Px (U/L) | TAS (mmol/L) | ||||
|---|---|---|---|---|---|---|
Control group | MS patients | Control group | MS patients | Control group | MS patients | |
mean ± SD | mean ± SD | mean ± SD | mean ± SD | mean ± SD | mean ± SD | |
(n) | (n) | (n) | (n) | (n) | (n) | |
All subject | 79.2±20.6 | 55.2#± 16.2 | 8029.9± 2650.1 | 6676.1*± 2386.4 | 1.48± 0.41 | 1.03#± 0.37 |
(63) | (101) | (63) | (101) | (63) | (101) | |
A) Smoking | 87.6±24.4 | 54.9± 16.2 | 8548.4± 2221.5 | 6649.6± 2421.0 | 1.38± 0.31 | 0.95*A/B± 0.39 |
(26) | (45) | (26) | (45) | (26) | (45) | |
B) No-smoking | 79.4± 17.52 | 55.6±13.5 | 8536.1± 2919.6 | 6609.2± 1948.4 | 1.31± 0.41 | 1.14± 0.33 |
(37) | (56) | (37) | (56) | (37) | (56) | |
C) Taking ID | - | 55.4± 17.8 | 6911.9± 2480.9 | 0.92#C/D± 0.34 | ||
(52) | (52) | (52) | ||||
D) No-taking ID | - | 58.6± 14.8 | 6684.5± 2433.1 | 1.31± 0.31 | ||
(49) | (49) | (49) | ||||